Vanda Pharmaceuticals (VNDA) Change in Intangibles (2014 - 2026)

Vanda Pharmaceuticals has disclosed Change in Intangibles across 4 years of filings, most recently posting $10.0 million for Q1 2026.

• Change in Intangibles for Q1 2026 came in at $10.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (changed N/A YoY), and the FY2025 annual result was $10.0 million, up 138.1% from the prior year.
• Change in Intangibles came in at $10.0 million for Q1 2026 at Vanda Pharmaceuticals, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $10.0 million in Q4 2025 to a low of $10.0 million in Q4 2025.